Introduction {#sec1}
============

A cohort study is one of the ways to evaluate the relationship between lifestyle factors and the incidence or mortality from non-communicable diseases. Although huge amounts of money and long-term observation are needed to conduct a cohort study, such a design could minimize selection bias and maximized external validity. Large-scale prospective cohorts focused on healthy populations (e.g., the Japan Collaborative Cohort \[JACC\] Study[@bib1] or the Japan Public Health-Based Prospective Cohort \[JPHC\] Study[@bib2]) have been conducted since 1980s in Japan. There have also been large cohort studies worldwide, such as the National Institutes of Health--American Association of Retired Persons Diet and Health Study in the United States,[@bib3] the European Prospective Investigation into Cancer and Nutrition in Europe,[@bib4] and the Korean Multi-center Cancer Cohort Study in Korea.[@bib5] Indeed, many findings have been obtained from these studies.

The Three-Prefecture Cohort Study was a prospective population-based observational study launched in 1983, which targeted approximately 100,000 inhabitants in Miyagi Prefecture, Aichi Prefecture, and Osaka Prefecture in Japan and conducted a questionnaire survey to reveal the association of multiphasic lifestyle factors with cancer incidence or mortality. Here, we briefly described the study concept and the cohort population\'s profile.

Materials and methods {#sec2}
=====================

Study design and settings {#sec2.1}
-------------------------

This cohort, which has been under prospective observation since 1983, was studied to assess the long-term effects of air pollution on mortality from lung cancer and respiratory diseases.[@bib6], [@bib7] The study areas were chosen because they contained a national air monitoring station and had well-managed cancer surveillance systems in 1983, including eight selected urban/rural areas in Miyagi Prefecture (Sendai City and Wakuya/Tajiri Town), Aichi Prefecture (Nagoya City and Inuyama City), and Osaka Prefecture (Osaka City and Nose/Kanan/Kumatori Town). Since the 1970s, there has been a network of ambient air monitoring stations in Japan operated by the Ministry of Environment (formerly the National Environment Agency) and local governments. In this study, we defined rural areas as cities/towns with general air pollution monitoring stations (control area) and urban areas as cities/towns with automobile exhaust gas measurement stations (pollution area).[@bib6] Self-administered questionnaires in sealed envelopes were distributed by hand to targeted individuals in cooperation with the municipal government in each area and were collected after a set period of time. The study committee, consisting of health center directors, local officials, and residents\' association representatives, was established to protect personal information of the participants and ensure the accuracy of the study. In this study, we merged individuals\' data with their cancer incidence information based on personal name, gender, and date of birth. The proportion of death certificate only (DCO) deaths in each area was 9.1%--17.8% in Miyagi Prefecture,[@bib8] 28.1%--32.6% in Aichi Prefecture,[@bib9] and 20.7%--23.4% in Osaka Prefecture.[@bib10]

The study subjects were residents aged ≥40 years who received a questionnaire, and they were enrolled between 1983 and 1985. The investigation was begun in Osaka Prefecture in 1983, in Miyagi Prefecture in 1984, and in Aichi Prefecture in 1985. The number of questionnaire responders was 17,195/17,805 (96.6%) in Sendai City, 14,574/14,926 (97.6%) in Wakuya/Tajiri Town, 21,535/23,331 (92.3%) in Nagoya City, 12,003/12,815 (93.7%) in Inuyama City, 20,665/27,051 (76.4%) in Osaka City, and 18565/21,101 (88.0%) in Nose/Kanan/Kumatori Town ([Table 1](#tbl1){ref-type="table"}). Of 104,537 responders, a total of 100,629 were included as subjects, after excluding those who answered a questionnaire in duplicate or did not provide their name/gender/date of birth because investigators could not follow up the outcome data in the Three-Prefecture Cohort study.

Questionnaire {#sec2.2}
-------------

Baseline questionnaire items included the following: area of residence, gender, height, weight, health condition at that time, past medical history, type of insurance, health check-up/cancer screening history, frequency of food intake, smoking, alcohol drinking status, parent\'s medical history, smoking status of cohabitants, house environment, occupation (such as the longest period of employment), and reproductive history (only for women). Medical history included: past history of diabetes mellitus, hypertension, stroke, and emphysema; and stomach cancer screening by x-ray examination, blood pressure measurement, and uterus cancer screening (only for women). Food intake frequency of items, such as rice, bread, meat, fish, eggs, milk, green/yellow vegetables, non-green/yellow vegetables, fruit, miso soup, and pickled vegetables, as well as drinking beverages, such as green tea, black tea, and coffee, was assessed categorically.

Follow-up {#sec2.3}
---------

The follow-up period was defined as 15 years from the baseline survey in each study area, except for cancer incidence data in Miyagi Prefecture, for which follow-up was 9 years. The cohorts were followed from 1984 to 1999 in Miyagi Prefecture, from 1985 to 2000 in Aichi Prefecture, and from 1983 to 2000 in Osaka Prefecture. Vital status, date of death, and date of move-out from the study area were confirmed by the local government using residence certificates. Cause of death was identified using death certificate. Cancer incidence and the date of diagnosis were collected from local cancer registry data.

Statistical analysis {#sec2.4}
--------------------

The definition of disease was determined based on the International Classification of Diseases 9th version (ICD-9) for data collected from 1983 to 1994 and or the 10th version (ICD-10) for data collected from 1995 to 2000 in this study. We counted the number of incident cancers and deaths of all cancer and cancer of individual sites, and also the number of deaths according to cause of death. When mortality rates were calculated, person-years of follow-up for mortality were counted from the date of the baseline survey to the date of death, date of move-out from the study area, or the end of 15-year follow-up (whichever occurred first). For cancer incidence rates, date of diagnosis of first primary cancer was added to the above list. In addition, standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) of all-cause and all cancer were calculated using age-adjusted mortality/incidence rate, which was calculated using 5-year age-specific rates in each year according to the cancer registry and vital statistics in Japan.[@bib11], [@bib12] Statistical analyses were implemented using STATA version 13 MP (Stata Corp., College Station, TX, USA).

Ethics {#sec2.5}
------

The study was approved by the institutional review board of the National Cancer Center and the Ethics Committee of Osaka University School of Medicine. We received permission from the municipal governments to survey residents. The response to the questionnaire by participant was considered consent to participate in the survey. Tohoku University, Aichi Cancer Center, and Osaka Medical Center for Cancer and Cardiovascular Diseases were primarily responsible for analyzing information on baseline surveys, linking with cancer incidence and cause of death data, and altering the data set to unlinkable anonymized data. Although the National Cancer Center had originally managed the integrated datasets, Osaka University manages them at present. In the Three-Prefecture Cohort study, researchers only analyzed unlinkable anonymous data.

Results {#sec3}
=======

Of 100,629 participants aged 40--99 years old at baseline, 19 (0.02%) were excluded because their responses preceded the date of beginning of follow-up, which was unified in each area after various dates of individual response to the questionnaire. As a result, 46,421 men and 54,189 women were eligible for this study. Details of the distribution of cohort participants at baseline by sex, age, and region are noted in [Table 2](#tbl2){ref-type="table"}. The person-years of follow-up for cancer incidence were 464,664 and 567,271 for men and women, respectively, and the person-years for death were 527,940 and 648,601 for men and women, respectively.

[Table 3](#tbl3){ref-type="table"} shows selected baseline characteristics of participants by sex. Mean age among men and women was 56.1 and 57.1 years, respectively, and the proportion of participants with a body mass index of 22.0--24.9 kg/m^2^ was 37.0% among men and 31.9% among women. The proportion of current drinkers of alcoholic beverages was 46.9% for men and 5.4% for women, and the proportion of current smokers was 51.6% for men and 9.6% for women. Regarding the longest period occupational classification, the proportion of participants engaged in clerical work was 11.7% among men and 9.6% among women, and the proportion of those unemployed was 2.8% among men and 19.7% among women.

[Table 4](#tbl4){ref-type="table"} shows the follow-up results, [Table 5](#tbl5){ref-type="table"} lists major types of incident cancers, and [Table 6](#tbl6){ref-type="table"} lists major causes of death by gender. There were 20,240 total deaths (20.1%; 11,156 men and 9084 women), and 20,281 move-outs (20.2%; 9145 men and 11,136 women) ([Table 4](#tbl4){ref-type="table"}). The SIR of all cancers was 0.96 among men and 1.22 among women. The SMR of all causes was 0.91 among men and women, and the SMR of all cancers was 1.02 among men and 0.97 among women. Stomach cancer was the most frequent cancer among men (25.5%) and women (18.7%), followed by lung cancer among men (17.1%) and breast cancer among women (13.0%) ([Table 5](#tbl5){ref-type="table"}). The leading cause of death was cancer among men (35.0%) and cardiovascular disease among women (41.0%), and the second-leading cause of death was cardiovascular disease among men (33.0%) and cancer among women (25.7%) ([Table 6](#tbl6){ref-type="table"}). Among those who died of cancer, the first-, second-, and third-leading causes of death were cancer of the lung (21.9%), stomach (21.2%), and liver (14.4%) among men, and cancer of the stomach (18.7%), colon/rectum (13.2%), and lung (11.8%) among women.

Discussion {#sec4}
==========

The Three-Prefecture Cohort Study, which had approximately 100,000 participants with consecutive follow-up for up to 15 years and a 90% response rate to the baseline questionnaire survey regarding participants\' lifestyles, was one of the largest representative prospective, population-based cohort studies in Japan. The study areas were selected because they contained national air monitoring stations and the community-based cancer registry was conducted actively; this large-scale observation enabled us to determine not only all-cause mortality but also cancer incidence among community residents. The association of air pollution and lung cancer mortality was reported previously.[@bib6] This report briefly describes the characteristics (e.g., smoking status, alcohol drinking status, and type of occupation) and endpoints among study participants by gender.

This study had several strengths. First, more than 100,000 participants answered a baseline questionnaire survey, and the response rate was approximately 90%. This response rate was similar to those of the JACC Study, which was launched in the mid-1980s,[@bib1] and the JPHC Study, which was launched in the 1990s.[@bib2] Many cohort studies in Japan have focused on residents in rural areas in order to conduct long-term follow-up.[@bib1], [@bib2] However, since this study included both urban and rural areas, findings from this cohort may help to evaluate the relationship between lifestyles and various diseases, irrespective of area. This study population was similar to the general population in cancer and mortality risks, with SIR and SMR close to 1.0.[@bib11], [@bib12] Considering the large sample size, the high questionnaire response rate, and adequate regional balance, we consider that the association between participants\' lifestyles and endpoints measured in this study is generalizable to the whole population of Japan. Second, in contrast to other large-scale cohorts in Japan, the collection of detailed information on participants\' occupation, such as the longest period of employment, is another strength of this study, and we will address the association between occupation and incidence and mortality of non-communicable diseases in the future using this cohort data. Third, the use of community-based cancer incidence data from a cohort of 100,000 participants was also a strength of this study, because there are few available analyses of cancer incidence data from large-scale cohort studies in Japan. Fourth, this cohort can be pooled with other large-scale cohorts in Japan (e.g., the JACC Study,[@bib1] the JPHC Study,[@bib2] or the Ohsaki Cohort[@bib13]) and serve to provide new findings from Japan.

This study has several limitations. First, this registry was launched in the 1980s and its follow-up of participants was completed in 2000. The associations between participants\' lifestyles and endpoints might differ from those since 2000, because lifestyles diversify with the times. Second, in cohort studies, non-questionnaire responders had more unfavorable lifestyles than responders[@bib2], [@bib14], [@bib15], [@bib16] and were less likely to join the health check-ups.[@bib2] However, the overall response rate in this cohort was almost 90%, and we consider that the impact of differences between responders in cities and those in towns would be small. Furthermore, the numbers of delivered questionnaires in Sendai City and Osaka City were fewer than those in other cities/towns, because residents\' local organizations did not cover the entire community and could not deliver questionnaires in the whole region. Therefore, the representativeness would be weaker in these areas than in other areas. Third, we could not evaluate the energy intake or nutrient consumption of participants because the Three-Prefecture Cohort Study used a food frequency questionnaire with a small number of items.

Conclusions {#sec5}
===========

The Three-Prefecture Cohort Study was conducted from the 1980s to 2000 and is one of the largest representative prospective population-based cohort studies in Japan. This study enabled us to reveal the association of multiphasic lifestyle factors with cancer incidence and mortality in a single cohort. It will also allow us to conduct a pooled analysis in combination with other large-scale cohorts, which will be of considerable help in gaining insights into the epidemiology of non-communicable diseases in Japan.
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###### 

Participants of the Three-Prefecture Cohort study.

Table 1

                                                        Miyagi Prefecture   Aichi Prefecture   Osaka Prefecture   Total                      
  ----------------------------------------------------- ------------------- ------------------ ------------------ -------- -------- -------- ---------
  All residents aged ≥40 years old                      25,237              15,891             24,489             12,854   39,307   21,230   139,008
  Delivered questionnaires                              17,805              14,926             23,331             12,815   27,051   21,101   117,029
  Responded questionnaires                              17,195              14,574             21,535             12,003   20,665   18,565   104,537
  Response rate (%)[a](#tbl1fna){ref-type="table-fn"}   (68.1)              (91.7)             (87.9)             (93.4)   (52.6)   (87.4)   (75.2)
  Response rate (%)[b](#tbl1fnb){ref-type="table-fn"}   (96.6)              (97.6)             (92.3)             (93.7)   (76.4)   (88.0)   (89.3)

Denominator was subjects who were all residents aged ≥40 years old.

Denominator was subjects who were delivered the self-administrated questionnaire.

###### 

Distribution of cohort participants at baseline by gender, age, and region.

Table 2

                                           Age at baseline, years   Total   \%                                                              
  ---------------------------------------- ------------------------ ------- ------ ------ ------ ------ ------ ------ ------ ----- -------- -------
  Men                                                                                                                                       
   Japan census population 1985 (x1,000)   4494                     4053    3898   3391   2349   1771   1486   997    546    247   23,232   
   %                                       19.3                     17.4    16.8   14.6   10.1   7.6    6.4    4.3    2.4    1.1            100.0
   Three-prefecture cohort participants    8082                     7735    7795   6804   5018   4067   3410   2153   973    384   46,421   
   %                                       17.4                     16.7    16.8   14.7   10.8   8.8    7.3    4.6    2.1    0.8            100.0
   Miyagi Prefecture (urban)               1137                     1161    1194   1057   859    765    586    371    189    72    7391     15.9
   Miyagi Prefecture (rural)               903                      1020    1213   1082   784    607    490    333    116    53    6601     14.2
   Aichi Prefecture (urban)                1841                     1821    1760   1358   1035   818    675    442    220    74    10,044   21.6
   Aichi Prefecture (rural)                1095                     989     963    823    561    476    377    250    109    49    5692     12.3
   Osaka Prefecture (urban)                990                      1161    1265   1183   927    764    718    440    193    67    7708     16.6
   Osaka Prefecture (rural)                2116                     1583    1400   1301   852    637    564    317    146    69    8985     19.4
  Women                                                                                                                                     
   Japan census population 1985 (x1,000)   4554                     4140    3971   3574   3011   2394   2046   1438   906    525   26,559   
   %                                       17.1                     15.6    15.0   13.5   11.3   9.0    7.7    5.4    3.4    2.0            100.0
   Three-prefecture cohort participants    8522                     8522    8337   7814   6604   5196   4261   2722   1471   740   54,189   
   %                                       15.7                     15.7    15.4   14.4   12.2   9.6    7.9    5.0    2.7    1.4            100.0
   Miyagi Prefecture (urban)               1318                     1447    1508   1379   1234   937    740    453    257    110   9383     17.3
   Miyagi Prefecture (rural)               938                      1161    1354   1268   1009   758    717    391    220    154   7970     14.7
   Aichi Prefecture (urban)                1911                     1944    1785   1621   1361   1020   843    578    264    141   11,468   21.2
   Aichi Prefecture (rural)                1071                     1050    897    869    711    638    459    346    171    94    6306     11.6
   Osaka Prefecture (urban)                1264                     1380    1404   1377   1246   1031   820    501    291    125   9439     17.4
   Osaka Prefecture (rural)                2020                     1540    1389   1300   1043   812    682    453    268    116   9623     17.8

###### 

Selected baseline demographic and lifestyle characteristics of participants by gender.

Table 3

                                                          Men             Women
  ------------------------------------------------------- --------------- ---------------
  Mean age, years (standard deviation)                    56.1 (11.2)     57.1 (11.6)
  Regions, n (%)                                                          
   Miyagi, urban                                          7391 (15.9)     9383 (17.3)
   Miyagi, rural                                          6601 (14.2)     7970 (14.7)
   Aichi, urban                                           10,044 (21.6)   11,468 (21.2)
   Aichi, rural                                           5692 (12.3)     6306 (11.6)
   Osaka, urban                                           7708 (16.6)     9439 (17.4)
   Osaka, rural                                           8985 (19.4)     9623 (17.8)
  Health insurance type, n (%)                                            
   National health insurance                              20,877 (45.0)   25,263 (46.6)
   Government/union-managed health insurance              19,267 (41.5)   20,864 (38.5)
   Mutual aid associations health insurance               3897 (8.4)      4250 (7.8)
   Others                                                 577 (1.2)       891 (1.6)
   Missing                                                1803 (3.9)      2921 (5.4)
  History of hypertension, n (%)                                          
   Current                                                8289 (17.9)     10,138 (18.7)
   Past                                                   1709 (3.7)      2189 (4.0)
   Never                                                  19,820 (42.7)   23,811 (43.9)
   Missing                                                16,603 (35.8)   18,051 (33.3)
  History of diabetes, n (%)                                              
   Current                                                2725 (5.9)      1803 (3.3)
   Past                                                   738 (1.6)       275 (0.5)
   Never                                                  20,895 (45.0)   25,586 (47.2)
   Missing                                                22,063 (47.5)   26,525 (48.9)
  Body mass index, n (%)                                                  
   ≤19.0 kg/m2                                            4310 (9.3)      6255 (11.5)
   19.0--21.9 kg/m2                                       14,995 (32.3)   17,153 (31.7)
   22.0--24.9 kg/m2                                       17,155 (37.0)   17,294 (31.9)
   25.0--29.9 kg/m2                                       7528 (16.2)     9378 (17.3)
   ≥30.0 kg/m2                                            515 (1.1)       1130 (2.1)
   Missing                                                1918 (4.1)      2979 (5.5)
  Alcohol drinking, n (%)                                                 
   Never                                                  7122 (15.3)     26,119 (48.2)
   Former                                                 2787 (6.0)      1094 (2.0)
   Current occasional                                     11,884 (25.6)   13,497 (24.9)
   Current almost daily                                   21,776 (46.9)   2942 (5.4)
   Missing                                                2852 (6.1)      10,537 (19.4)
  Smoking status, n (%)                                                   
   Never                                                  7411 (16.0)     37,281 (68.8)
   Former                                                 10,805 (23.3)   1746 (3.2)
   Current                                                23,969 (51.6)   5199 (9.6)
   Missing                                                4236 (9.1)      9963 (18.4)
  Green and yellow vegetable consumption, n (%)                           
   ≤1--2 times/month                                      3311 (7.1)      2183 (4.0)
   1--2 times/week                                        10,320 (22.2)   8563 (15.8)
   3--4 times/week                                        12,623 (27.2)   14,918 (27.5)
   Almost daily                                           17,509 (37.7)   24,445 (45.1)
   Missing                                                2658 (5.7)      4080 (7.5)
  Non-green and non-yellow vegetable consumption, n (%)                   
   ≤1--2 times/month                                      1491 (3.2)      1111 (2.1)
   1--2 times/week                                        6634 (14.3)     5229 (9.6)
   3--4 times/week                                        12,267 (26.4)   12,816 (23.7)
   Almost daily                                           23,782 (51.2)   31,276 (57.7)
   Missing                                                2247 (4.8)      3757 (6.9)
  Fruit consumption, n (%)                                                
   ≤1--2 times/month                                      5040 (10.9)     2452 (4.5)
   1--2 times/week                                        9631 (20.7)     6291 (11.6)
   3--4 times/week                                        10,303 (22.2)   10,649 (19.7)
   Almost daily                                           18,308 (39.4)   30,535 (56.3)
   Missing                                                3139 (6.8)      4262 (7.9)
  Miso soup consumption, n (%)                                            
   ≤1--2 times/month                                      3141 (6.8)      3823 (7.1)
   1--2 times/week                                        7127 (15.4)     8473 (15.6)
   3--4 times/week                                        8035 (17.3)     9746 (18.0)
   Almost daily                                           25,913 (55.8)   28,213 (52.1)
   Missing                                                2205 (4.8)      3934 (7.3)
  Pickled vegetable consumption, n (%)                                    
   Scarcely any                                           2296 (4.9)      2095 (3.9)
   1--2 times/month                                       2311 (5.0)      2380 (4.4)
   1--2 times/week                                        5114 (11.0)     5340 (9.9)
   3--4 times/week                                        6508 (14.0)     6753 (12.5)
   Almost daily                                           27,016 (58.2)   32,802 (60.5)
   Missing                                                3176 (6.8)      4819 (8.9)
  Type of job, n (%)                                                      
   Professional technical and civil workers               3835 (8.3)      2805 (5.2)
   Managerial workers                                     959 (2.1)       98 (0.2)
   Clerical workers                                       5415 (11.7)     5197 (9.6)
   Sales workers                                          5495 (11.8)     3663 (6.8)
   Agricultural, forestry and fisheries workers           2844 (6.1)      3127 (5.8)
   Construction workers                                   92 (0.2)        9 (0.0)
   Workers in transport and communications                1814 (3.9)      309 (0.6)
   Craftsman, production process worker, and laborers     9537 (20.5)     4740 (8.7)
   Workers in security                                    567 (1.2)       18 (0.0)
   Service workers                                        1069 (2.3)      2750 (5.1)
   Unemployed                                             1284 (2.8)      10,666 (19.7)
   Missing                                                13,510 (29.1)   20,807 (38.4)

###### 

15-year follow-up status until 2000 by gender and age.

Table 4

                                                            Age at baseline, years   Total                                                                             
  --------------------------------------------------------- ------------------------ --------- --------- --------- -------- -------- -------- -------- ------- ------- ---------
  Men                                                                                                                                                                  
   Number at baseline                                       8082                     7735      7795      6804      5018     4067     3410     2153     973     384     46,421
   Number of all cancer incidences                          215                      371       665       891       841      802      712      414      159     36      5106
   % (Number of all cancer incidences/Number at baseline)   2.7                      4.8       8.5       13.1      16.8     19.7     20.9     19.2     16.3    9.4     11.0
   Number of deaths                                         320                      506       960       1268      1407     1790     2054     1642     850     359     11,156
   % (Number of all cause deaths/Number at baseline)        4.0                      6.5       12.3      18.6      28.0     44.0     60.2     76.3     87.4    93.5    24.0
   Number of all cancer deaths                              135                      230       463       642       615      641      626      375      140     35      3902
   % (Number of all cancer deaths/Number at baseline)       1.7                      3.0       5.9       9.4       12.3     15.8     18.4     17.4     14.4    9.1     8.4
   Number who left study area                               2359                     1991      1608      1151      735      558      421      226      80      16      9145
   % (Number who left study area/Number at baseline)        29.2                     25.7      20.6      16.9      14.6     13.7     12.3     10.5     8.2     4.2     19.7
   Person-years (incidence)                                 87,758                   83,560    83,345    71,783    50,831   37,773   28,223   14,550   5175    1666    464,664
   Incidence rate (all cancer per 1000 person-years)        2.4                      4.4       8.0       12.4      16.5     21.2     25.2     28.5     30.7    21.6    11.0
   Person-years (mortality)                                 96,389                   93,649    95,428    83,102    59,579   44,107   32,193   16,278   5500    1714    527,940
   Mortality rate (all cause per 1000 person-years)         3.3                      5.4       10.1      15.3      23.6     40.6     63.8     100.9    154.5   209.4   21.1
   Mortality rate (all cancer per 1000 person-years)        1.4                      2.5       4.9       7.7       10.3     14.5     19.4     23.0     25.5    20.4    7.4
  Women                                                                                                                                                                
   Number at baseline                                       8522                     8522      8337      7814      6604     5196     4261     2722     1471    740     54,189
   Number of cancer incidences                              229                      291       386       483       513      539      478      296      121     37      3373
   % (Number of all cancer incidences/Number at baseline)   2.7                      3.4       4.6       6.2       7.8      10.4     11.2     10.9     8.2     5.0     6.2
   Number of deaths                                         181                      301       446       662       946      1365     1712     1648     1157    666     9084
   % (Number of all cause deaths/Number at baseline)        2.1                      3.5       5.3       8.5       14.3     26.3     40.2     60.5     78.7    90.0    16.8
   Number of all cancer deaths                              98                       170       211       286       325      410      404      278      115     34      2331
   % (Number of all cancer deaths/Number at baseline)       1.1                      2.0       2.5       3.7       4.9      7.9      9.5      10.2     7.8     4.6     4.3
   Number who left study area                               2242                     2051      1693      1483      1233     1012     758      440      166     58      11,136
   % (Number who left study area/Number at baseline)        26.3                     24.1      20.3      19.0      18.7     19.5     17.8     16.2     11.3    7.8     20.6
   Person-years (incidence)                                 94,984                   94,636    92,190    85,763    71,427   53,084   40,224   22,468   9322    3172    567,271
   Incidence rate (all cancer per 1000 person-years)        2.4                      3.1       4.2       5.6       7.2      10.2     11.9     13.2     13.0    11.7    5.9
   Person-years (mortality)                                 105,776                  107,461   107,287   100,096   83,052   60,982   46,008   24,740   9927    3272    648,601
   Mortality rate (all cause per 1000 person-years)         1.7                      2.8       4.2       6.6       11.4     22.4     37.2     66.6     116.6   203.5   14.0
   Mortality rate (all cancer per 1000 person-years)        0.9                      1.6       2.0       2.9       3.9      6.7      8.8      11.2     11.6    10.4    3.6

###### 

Distribution of number of cancer incidence by site, gender, and age at baseline during 15-year follow-up.

Table 5

  ICD10        ICD9                                                          Age at baseline, years   Total   \%                                                    
  ------------ -------------- ---------------------------------------------- ------------------------ ------- ----- ----- ----- ----- ----- ----- ----- ---- ------ -------
  Men                                                                                                                                                               
   C00-C97     140--208.9     all cancer                                     215                      371     665   891   841   802   712   414   159   36   5106   100.0
   C15         150--150.9     Esophagus                                      14                       20      25    43    35    29    29    8     4     0    207    4.1
   C16         151--151.9     Stomach                                        52                       94      180   235   224   191   187   95    34    10   1302   25.5
   C18         153--153.9     Colon                                          26                       40      78    74    75    75    52    37    19    1    477    9.3
   C19-20      154--154.9     Rectum                                         18                       28      29    44    46    33    23    21    3     1    246    4.8
   C22         155--155.9     Liver and intrahepatic bile ducts              24                       58      117   137   82    83    57    33    15    2    608    11.9
   C23         156            Gall bladder                                   0                        2       3     3     2     3     4     2     0     0    19     0.4
   C24         156.1--156.9   Other and unspecified parts of biliary tract   4                        4       11    9     11    20    15    8     4     2    88     1.7
   C25         157--157.9     Pancreas                                       10                       10      19    34    37    33    29    21    8     2    203    4.0
   C33-34      162--162.9     Lung                                           24                       38      79    120   160   174   160   85    25    8    873    17.1
   C61         185--185.9     Prostate                                       1                        7       10    39    31    41    35    25    15    2    206    4.0
   C64         189--189.1     Kidney                                         3                        10      8     21    14    11    8     7     0     0    82     1.6
   C65-67      189.2--189.4   Urothelial tract                               2                        9       4     11    9     13    11    3     2     0    64     1.3
   C82-85      202--202.9     Non-Hodgkin\'s                                 3                        5       10    10    12    7     8     5     2     3    65     1.3
  200--200.9                                                                                                                                                        
   C90         203--203.8     Multiple myeloma                               1                        0       5     3     8     3     0     3     1     0    24     0.5
   C92         205--205.9     Myeloid leukemia                               4                        3       7     6     5     7     3     3     1     2    41     0.8
  Women                                                                                                                                                             
   C00-C97     140--208.9     all cancer                                     229                      291     386   483   513   539   478   296   121   37   3373   100.0
   C15         150--150.9     Esophagus                                      0                        1       1     4     4     5     5     5     0     0    25     0.7
   C16         151--151.9     Stomach                                        32                       49      59    83    104   103   96    63    35    6    630    18.7
   C18         153--153.9     Colon                                          10                       35      44    54    53    67    59    41    12    6    381    11.3
   C19-20      154--154.9     Rectum                                         15                       15      24    25    29    28    27    11    10    2    186    5.5
   C22         155--155.9     Liver and intrahepatic bile ducts              5                        14      22    31    38    43    29    11    8     2    203    6.0
   C23         156            Gall bladder                                   0                        3       3     3     5     5     4     6     0     0    29     0.9
   C24         156.1--156.9   Other and unspecified parts of biliary tract   2                        3       5     8     12    21    16    13    5     2    87     2.6
   C25         157--157.9     Pancreas                                       3                        6       9     26    25    35    28    19    5     1    157    4.7
   C33-34      162--162.9     Lung                                           16                       8       26    42    52    56    60    34    10    5    309    9.2
   C50         174--175.9     Breast                                         72                       74      71    73    58    42    30    13    6     0    439    13.0
   C53         180--180.9     Cervi uteri                                    16                       17      8     22    15    14    17    8     1     0    118    3.5
   C54         182--182.9     Corpus uteri                                   9                        13      22    15    7     8     4     0     0     0    78     2.3
   C55         184--184.9     Uterus, part unspecified                       0                        0       1     1     2     3     1     1     2     0    11     0.3
   C56         183--183.9     Ovary                                          15                       13      18    12    8     10    12    7     4     0    99     2.9
   C64         189--189.1     Kidney                                         2                        1       4     3     2     2     5     1     3     0    23     0.7
   C65-67      189.2--189.4   Urothelial tract                               0                        0       4     3     5     7     3     3     0     1    26     0.8
   C82-85      200--200.9     Non-Hodgkin\'s                                 2                        3       4     10    7     6     6     5     4     1    48     1.4
  202--202.9                                                                                                                                                        
   C90         203--203.8     Multiple myeloma                               0                        0       3     4     4     4     6     3     1     1    26     0.8
   C92         205--205.9     Myeloid leukemia                               4                        5       3     4     3     6     1     2     0     0    28     0.8

###### 

Distribution of number of deaths by cause, gender, and age at baseline during 15-year follow-up.

Table 6

  ICD10         ICD9                                                                                                      Age at baseline, years   Total   \%    \%                                                               
  ------------- -------------- ------------------------------------------------------------------------------------------ ------------------------ ------- ----- ------ ------ ------ ------ ------ ------ ----- -------- ------- -------
  Men                                                                                                                                                                                                                             
   All causes                                                                                                             320                      506     960   1268   1407   1790   2054   1642   850    359   11,156   100.0   
   A00-B99      1--139.8       Certain infectious and parasitic diseases                                                  22                       11      38    40     31     46     35     28     10     6     267      2.4     
   C00-C97      140--208.9     all cancer                                                                                 135                      230     463   642    615    641    626    375    140    35    3902     35.0    100.0
   C15          150--150.9     Esophagus                                                                                  15                       13      22    41     32     27     26     9      7      0     192              4.9
   C16          151--151.9     Stomach                                                                                    28                       39      104   126    120    137    151    84     29     11    829              21.2
   C18          153--153.9     Colon                                                                                      10                       17      38    40     41     47     33     30     13     1     270              6.9
   C19-20       154--154.9     Rectum                                                                                     10                       10      20    25     27     19     19     19     4      1     154              3.9
   C22          155--155.9     Liver and intrahepatic bile ducts                                                          16                       52      107   127    80     76     60     29     14     2     563              14.4
   C23          156            Gall bladder                                                                               0                        4       4     4      10     9      6      4      0      1     42               1.1
   C24          156.1--156.9   Other and unspecified parts of biliary tract                                               3                        6       11    8      13     21     14     12     5      2     95               2.4
   C25          157--157.9     Pancreas                                                                                   9                        14      21    39     41     36     33     23     6      2     224              5.7
   C33-34       162--162.9     Lung                                                                                       22                       36      66    123    152    165    171    89     24     8     856              21.9
   C61          185--185.9     Prostate                                                                                   0                        4       7     11     20     27     24     16     13     1     123              3.2
   C64          189--189.1     Kidney                                                                                     0                        3       3     6      8      8      6      3      0      0     37               0.9
   C65-67       189.2--189.4   Urothelial tract                                                                           0                        0       1     4      2      3      3      1      0      0     14               0.4
   C82-85       200--200.9     Non-Hodgkin\'s                                                                             3                        2       9     12     11     10     13     8      2      2     72               1.8
  202--202.9                                                                                                                                                                                                                      
   C90          203--203.8     Multiple myeloma                                                                           1                        1       3     2      5      3      2      3      0      0     21               0.5
   C92          205--205.9     Myeloid leukemia                                                                           3                        3       6     5      8      6      4      2      1      2     40               1.0
   E00-E89      240--279.9     Endocrine, nutritional and metabolic diseases                                              0                        6       9     14     20     29     19     26     17     3     143      1.3     
   G00-G99      330--359.9     Diseases of the nervous system                                                             1                        5       6     9      12     18     10     8      3      0     72       0.6     
   I00-I99      390--459.9     Diseases of the circulatory system                                                         76                       121     242   304    407    578    772    644    364    173   3681     33.0    
   I20-I25      410--414.9     Ischemic heart disease                                                                     16                       33      62    74     116    142    176    115    60     16    810              
   I48          427.3          Atrial fibrillation and flutter                                                            0                        0       3     2      1      6      7      6      4      2     31               
   I50          428--428.9     Heart failure                                                                              23                       32      48    53     74     107    182    181    94     50    844              
   I60-69       430--438.9     Cerebrovascular disease                                                                    26                       42      87    130    143    216    308    270    166    88    1476             
   I71          441--441.9     Aortic aneurysm and dissection                                                             2                        2       5     8      15     21     13     8      5      2     81               
   J00-J99      460--519.9     Diseases of the respiratory system                                                         4                        14      41    76     134    255    351    299    161    59    1394     12.5    
   J10-J18      480--487.9     Influenza                                                                                  1                        8       15    46     68     139    228    198    113    40    856              
   J43          492            Emphysema                                                                                  0                        0       5     5      5      22     19     14     4      5     79               
   K00-K93      520--579.9     Diseases of the digestive system                                                           21                       39      63    61     59     69     62     59     27     6     466      4.2     
   K74          571.5--571.6   Fibrosis and cirrhosis of liver                                                            7                        14      38    26     22     17     12     10     6      0     152              
   N00-N99      580--629.9     Diseases of the genitourinary system                                                       4                        7       12    29     36     37     57     53     25     8     268      2.4     
   N17-N19      584--586       Acute kidney failure and chronic kidney disease                                            3                        7       11    21     32     28     48     43     17     2     212              
   R00-R99      780--799.9     Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified   7                        3       5     15     17     33     51     80     67     56    334      3.0     
   R54          797            Age-related physical debility                                                              1                        0       0     1      1      11     15     57     52     55    193              
   S00-T88      800--999.9     External causes                                                                            42                       56      60    57     53     43     41     35     21     5     413      3.7     
                               Others                                                                                     8                        14      21    21     23     41     30     35     15     8     216      1.9     
  Women                                                                                                                                                                                                                           
   All causes                                                                                                             181                      301     446   662    946    1365   1712   1648   1157   666   9084     100.0   
   A00-B99      1--139.8       Certain infectious and parasitic diseases                                                  6                        7       21    24     36     31     38     33     21     4     221      2.4     
   C00-C97      140--208.9     all cancer                                                                                 98                       170     211   286    325    410    404    278    115    34    2331     25.7    100.0
   C15          150--150.9     Esophagus                                                                                  0                        0       2     6      2      4      8      5      3      0     30               1.3
   C16          151--151.9     Stomach                                                                                    15                       29      35    49     51     74     80     65     31     7     436              18.7
   C18          153--153.9     Colon                                                                                      5                        16      22    27     25     30     46     33     10     5     219              9.4
   C19-20       154--154.9     Rectum                                                                                     3                        10      13    16     13     19     16     10     9      2     111              4.8
   C22          155--155.9     Liver and intrahepatic bile ducts                                                          4                        14      14    26     40     38     30     11     8      2     187              8.0
   C23          156            Gall bladder                                                                               1                        2       7     9      8      19     15     9      1      0     71               3.0
   C24          156.1--156.9   Other and unspecified parts of biliary tract                                               3                        6       8     7      13     21     14     16     7      2     97               4.2
   C25          157--157.9     Pancreas                                                                                   5                        6       12    32     25     40     30     18     6      2     176              7.6
   C33-34       162--162.9     Lung                                                                                       11                       12      17    36     38     55     57     33     11     5     275              11.8
   C50          174--175.9     Breast                                                                                     23                       29      22    16     22     16     11     8      3      0     150              6.4
   C53          180--180.9     Cervi uteri                                                                                5                        4       1     4      7      8      5      4      0      0     38               1.6
   C54          182--182.9     Corpus uteri                                                                               1                        4       4     3      0      3      7      0      0      0     22               0.9
   C55          184--184.9     Uterus, part unspecified                                                                   0                        0       0     1      2      1      1      0      2      0     7                0.3
   C56          183--183.9     Ovary                                                                                      8                        9       15    10     8      9      11     6      4      0     80               3.4
   C64          189--189.1     Kidney                                                                                     1                        0       0     3      0      1      7      1      3      0     16               0.7
   C65-67       189.2--189.4   Urothelial tract                                                                           0                        0       2     1      4      1      2      0      0      0     10               0.4
   C82-85       200--200.9     Non-Hodgkin\'s                                                                             1                        2       4     8      9      9      3      6      4      1     47               2.0
  202--202.9                                                                                                                                                                                                                      
   C90          203--203.8     Multiple myeloma                                                                           0                        1       3     4      4      5      8      4      1      0     30               1.3
   C92          205--205.9     Myeloid leukemia                                                                           2                        5       3     4      4      6      1      2      0      0     27               1.2
   E00-E89      240--279.9     Endocrine, nutritional and metabolic diseases                                              2                        4       5     12     18     20     37     29     15     3     145      1.6     
   G00-G99      330--359.9     Diseases of the nervous system                                                             3                        2       8     4      11     13     9      12     4      0     66       0.7     
   I00-I99      390--459.9     Diseases of the circulatory system                                                         33                       65      112   171    322    543    753    780    600    343   3722     41.0    
   I20-I25      410--414.9     Ischemic heart disease                                                                     4                        9       24    39     73     127    134    123    89     32    654              
   I48          427.3          Atrial fibrillation and flutter                                                            0                        0       0     2      0      3      7      8      2      1     23               
   I50          428--428.9     Heart failure                                                                              9                        8       20    28     71     124    164    218    173    118   933              
   I60-69       430--438.9     Cerebrovascular disease                                                                    12                       33      50    81     130    218    335    337    251    150   1597             
   I71          441--441.9     Aortic aneurysm and dissection                                                             1                        1       0     1      5      8      12     8      2      0     38               
   J00-J99      460--519.9     Diseases of the respiratory system                                                         7                        12      20    47     81     111    197    221    138    75    909      10.0    
   J10-J18      480--487.9     Influenza                                                                                  1                        4       8     25     44     72     133    149    98     67    601              
   J43          492            Emphysema                                                                                  0                        0       0     1      2      1      1      4      3      2     14               
   K00-K93      520--579.9     Diseases of the digestive system                                                           9                        9       24    39     38     62     68     68     54     26    397      4.4     
   K74          571.5--571.6   Fibrosis and cirrhosis of liver                                                            5                        5       10    18     17     22     22     10     2      0     111              
   N00-N99      580--629.9     Diseases of the genitourinary system                                                       3                        3       9     19     23     45     65     52     43     17    279      3.1     
   N17-N19      584--586       Acute kidney failure and chronic kidney disease                                            3                        3       8     17     18     33     50     38     29     16    215              
   R00-R99      780--799.9     Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified   2                        3       2     11     11     33     51     109    119    141   482      5.3     
   R54          797            Age-related physical debility                                                              0                        0       0     0      2      16     28     87     112    130   375              
   S00-T88      800--999.9     External causes                                                                            11                       18      15    31     50     52     46     26     21     11    281      3.1     
                               Others                                                                                     7                        8       19    18     31     45     44     40     27     12    251      2.8     
